These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 29116004)

  • 21. Reproductive and hormonal risk factors for postmenopausal luminal, HER-2-overexpressing, and triple-negative breast cancer.
    Phipps AI; Malone KE; Porter PL; Daling JR; Li CI
    Cancer; 2008 Oct; 113(7):1521-6. PubMed ID: 18726992
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reproductive factors and subtypes of breast cancer defined by estrogen receptor, progesterone receptor, and human epidermal growth factor receptor 2: a register-based study from Korea.
    Lee JS; Oh M; ;
    Clin Breast Cancer; 2014 Dec; 14(6):426-34. PubMed ID: 25034438
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reproductive risk factors associated with breast cancer in young women by molecular subtype.
    Ruddy KJ; Vierkant RA; Jahan N; Higgins A; Partridge A; Larson N; Radisky DC; Couch F; Olson J; Sherman ME
    Breast; 2022 Dec; 66():272-277. PubMed ID: 36375388
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Breast cancer risk factors in relation to molecular subtypes in breast cancer patients from Kenya.
    Sayed S; Fan S; Moloo Z; Wasike R; Bird P; Saleh M; Shaikh AJ; Figueroa JD; Naidoo R; Makokha FW; Gardner K; Oigara R; Njoroge FW; Magangane P; Mutebi M; Chauhan R; Mwanzi S; Govender D; Yang XR
    Breast Cancer Res; 2021 Jun; 23(1):68. PubMed ID: 34174935
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pooled Analysis of Nine Cohorts Reveals Breast Cancer Risk Factors by Tumor Molecular Subtype.
    Gaudet MM; Gierach GL; Carter BD; Luo J; Milne RL; Weiderpass E; Giles GG; Tamimi RM; Eliassen AH; Rosner B; Wolk A; Adami HO; Margolis KL; Gapstur SM; Garcia-Closas M; Brinton LA
    Cancer Res; 2018 Oct; 78(20):6011-6021. PubMed ID: 30185547
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reproductive risk factors in relation to molecular subtypes of breast cancer: Results from the nurses' health studies.
    Sisti JS; Collins LC; Beck AH; Tamimi RM; Rosner BA; Eliassen AH
    Int J Cancer; 2016 May; 138(10):2346-56. PubMed ID: 26684063
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Use of four biomarkers to evaluate the risk of breast cancer subtypes in the women's contraceptive and reproductive experiences study.
    Ma H; Wang Y; Sullivan-Halley J; Weiss L; Marchbanks PA; Spirtas R; Ursin G; Burkman RT; Simon MS; Malone KE; Strom BL; McDonald JA; Press MF; Bernstein L
    Cancer Res; 2010 Jan; 70(2):575-87. PubMed ID: 20068186
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of breast cancer risk factors among molecular subtypes: A case-only study.
    Zhang L; Huang Y; Feng Z; Wang X; Li H; Song F; Liu L; Li J; Zheng H; Wang P; Song F; Chen K
    Cancer Med; 2019 Apr; 8(4):1882-1892. PubMed ID: 30761775
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Breast feeding, parity and breast cancer subtypes in a Spanish cohort.
    Redondo CM; Gago-Domínguez M; Ponte SM; Castelo ME; Jiang X; García AA; Fernández MP; Tomé MA; Fraga M; Gude F; Martínez ME; Garzón VM; Carracedo Á; Castelao JE
    PLoS One; 2012; 7(7):e40543. PubMed ID: 22792365
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Distribution of molecular breast cancer subtypes among Algerian women and correlation with clinical and tumor characteristics: a population-based study.
    Cherbal F; Gaceb H; Mehemmai C; Saiah I; Bakour R; Rouis AO; Boualga K; Benbrahim W; Mahfouf H
    Breast Dis; 2015; 35(2):95-102. PubMed ID: 25736840
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reproductive history and the risk of molecular breast cancer subtypes in a prospective study of Norwegian women.
    Horn J; Opdahl S; Engstrøm MJ; Romundstad PR; Tretli S; Haugen OA; Bofin AM; Vatten LJ; Åsvold BO
    Cancer Causes Control; 2014 Jul; 25(7):881-9. PubMed ID: 24789514
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reproductive history and oral contraceptive use in relation to risk of triple-negative breast cancer.
    Phipps AI; Chlebowski RT; Prentice R; McTiernan A; Wactawski-Wende J; Kuller LH; Adams-Campbell LL; Lane D; Stefanick ML; Vitolins M; Kabat GC; Rohan TE; Li CI
    J Natl Cancer Inst; 2011 Mar; 103(6):470-7. PubMed ID: 21346227
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Body mass index and risk of luminal, HER2-overexpressing, and triple negative breast cancer.
    Chen L; Cook LS; Tang MT; Porter PL; Hill DA; Wiggins CL; Li CI
    Breast Cancer Res Treat; 2016 Jun; 157(3):545-54. PubMed ID: 27220749
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association of body composition with odds of breast cancer by molecular subtype: analysis of the Mechanisms for Established and Novel Risk Factors for Breast Cancer in Nigerian Women (MEND) study.
    Akinyemiju T; Jones K; Gupta A; Oyekunle T; Saraiya V; Deveaux A; Salako O; Hall A; Alatise O; Ogun G; Adeniyi A; Ayandipo O; Olajide T; Olasehinde O; Arowolo O; Adisa A; Afuwape O; Olusanya A; Adegoke A; Tollefsbol TO; Arnett D; ; Daramola A
    BMC Cancer; 2021 Sep; 21(1):1051. PubMed ID: 34563146
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Epidemiology of breast cancer subtypes in two prospective cohort studies of breast cancer survivors.
    Kwan ML; Kushi LH; Weltzien E; Maring B; Kutner SE; Fulton RS; Lee MM; Ambrosone CB; Caan BJ
    Breast Cancer Res; 2009; 11(3):R31. PubMed ID: 19463150
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A cumulative index of exposure to endogenous estrogens and breast cancer by molecular subtypes in northern Mexican women.
    Rojas-Lima E; Gamboa-Loira B; Cebrián ME; Rothenberg SJ; López-Carrillo L
    Breast Cancer Res Treat; 2020 Apr; 180(3):791-800. PubMed ID: 32086656
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reproductive factors and risk of breast cancer by tumor subtypes among Ghanaian women: A population-based case-control study.
    Figueroa JD; Davis Lynn BC; Edusei L; Titiloye N; Adjei E; Clegg-Lamptey JN; Yarney J; Wiafe-Addai B; Awuah B; Duggan MA; Wiafe S; Nyarko K; Aitpillah F; Ansong D; Hewitt SM; Ahearn T; Garcia-Closas M; Brinton LA;
    Int J Cancer; 2020 Sep; 147(6):1535-1547. PubMed ID: 32068253
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Menstrual and Reproductive Factors in Association With Breast Cancer Risk in Vietnamese Women: A Case-Control Study.
    Bui OT; Tran HT; Nguyen SM; Dao TV; Bui QV; Pham AT; Shrubsole MJ; Cai Q; Ye F; Zheng W; Luu HN; Tran TV; Shu XO
    Cancer Control; 2022; 29():10732748221140206. PubMed ID: 36373740
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reproductive and hormonal risk factors for luminal, HER2-overexpressing, and triple-negative breast cancer in Japanese women.
    Islam T; Matsuo K; Ito H; Hosono S; Watanabe M; Iwata H; Tajima K; Tanaka H
    Ann Oncol; 2012 Sep; 23(9):2435-2441. PubMed ID: 22328736
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Risk factors for breast cancer and their association with molecular subtypes in a population of Northeast Brazil.
    Gomes KAL; de Araújo Jerônimo AF; Guimarães CMC; de Oliveira Ramos R; Dos Santos Andrade LS; Weller M
    Cancer Epidemiol; 2022 Jun; 78():102166. PubMed ID: 35486969
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.